Single-cell transcriptomic analysis reveals APOE genotype-dependent sex differences in Alzheimer's disease
Single-cell brain mapping reveals sex-dependent genetic variations in Alzheimer's disease, laying groundwork for personalized therapeutic targets.
Mount Sinai researchers provide a high-resolution single-cell transcriptomic map of sex-by-APOE genotype interactions across 54 brain cell types in Alzheimer's disease, identifying candidate molecular targets for personalized AD interventions stratified by sex and genetic risk. This is exploratory omics science without clinical endpoints — provides a foundation for hypothesis-driven follow-up studies.
What the study was
- Study design
- Retrospective single-cell transcriptomics analysis
- Population
- Alzheimer's disease single-cell RNA-seq dataset; 54 cell types, multiple APOE genotypes and sex groups
- Category
- Genomics/Precision Medicine
- Maturity
- Exploratory
- Journal
- Alzheimer's & Dementia
Why it surfaced
High-quality single-cell genomics study from a leading AD center (Mount Sinai) providing sex-APOE interaction landscape. Exploratory but methodologically strong. Clinical translation pathway distant. Primarily relevant to aging/longevity and genomics pipeline tracks.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.